# RYTARY
> **NDA203312** · New Drug Application · Sponsor: IMPAX · Approved 2015-01-07
## Drug
- **FDA Application Number:** NDA203312
- **Application type:** New Drug Application
- **Brand name:** RYTARY
- **Generic name:** CARBIDOPA AND LEVODOPA
- **Active ingredients:** CARBIDOPA; LEVODOPA
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IMPAX
- **Manufacturer:** Zydus Pharmaceuticals USA Inc.
- **First approval:** 2015-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203312)
---
*MORVS · CC0 1.0*